• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

麻醉患者的血中丙泊酚水平。单次或重复给药后浓度与催眠活性的相关性。

Blood disoprofol levels in anesthetised patients. Correlation of concentrations after single or repeated doses with hypnotic activity.

作者信息

Adam H K, Kay B, Douglas E J

出版信息

Anaesthesia. 1982 May;37(5):536-40. doi: 10.1111/j.1365-2044.1982.tb01223.x.

DOI:10.1111/j.1365-2044.1982.tb01223.x
PMID:6979270
Abstract

The blood concentrations of disoprofol (Diprivan) after single intravenous doses of 1, 2 or 3 mg/kg have been examined in a subpopulation from previously reported clinical studies. The linear relationship between sleep time and dose could be explained by the linearity of the pharmacokinetics at these doses. After a single injection the awakening concentration was independent of dose, with a mean value of 1.04 micrograms/ml. No acute tolerance occurred with disoprofol. On repeated 1 mg/kg bolus injections the sleeping time rose initially but stabilised after four doses. The waking concentration was independent of the number of doses administered. The clinical findings fitted an agent with a very rapid distribution phase and a short elimination half-life.

摘要

在先前报告的临床研究的一个亚组中,检测了单次静脉注射1、2或3mg/kg丙泊酚(得普利麻)后的血药浓度。睡眠时间与剂量之间的线性关系可以用这些剂量下的药代动力学线性来解释。单次注射后,苏醒浓度与剂量无关,平均值为1.04微克/毫升。丙泊酚未出现急性耐受性。重复静脉推注1mg/kg时,睡眠时间最初会延长,但在四次给药后趋于稳定。苏醒浓度与给药次数无关。临床研究结果符合一种分布相非常迅速且消除半衰期短的药物。

相似文献

1
Blood disoprofol levels in anesthetised patients. Correlation of concentrations after single or repeated doses with hypnotic activity.麻醉患者的血中丙泊酚水平。单次或重复给药后浓度与催眠活性的相关性。
Anaesthesia. 1982 May;37(5):536-40. doi: 10.1111/j.1365-2044.1982.tb01223.x.
2
Dose-response relationship for disoprofol (ICI 35868; Diprivan). Comparison with methohexitone.丙泊酚(ICI 35868;得普利麻)的剂量-反应关系。与美索比妥的比较。
Anaesthesia. 1981 Sep;36(9):863-7. doi: 10.1111/j.1365-2044.1981.tb08858.x.
3
Pharmacokinetic evaluation of ICI 35 868 in man. Single induction doses with different rates of injection.ICI 35 868在人体中的药代动力学评估。不同注射速率的单次诱导剂量。
Br J Anaesth. 1983 Feb;55(2):97-103. doi: 10.1093/bja/55.2.97.
4
Pharmacokinetics in laboratory animals of ICI 35 868, a new i.v. anaesthetic agent.新型静脉麻醉剂ICI 35868在实验动物体内的药代动力学
Br J Anaesth. 1980 Aug;52(8):743-6. doi: 10.1093/bja/52.8.743.
5
Continuous intravenous infusion of disoprofol (ICI 35868, Diprivan). Comparison with Althesin to cover surgery under local analgesia.持续静脉输注双异丙酚(ICI 35868,得普利麻)。与阿法沙龙-阿法多龙比较用于局部镇痛下的手术。
Anaesthesia. 1982 Mar;37(3):295-300. doi: 10.1111/j.1365-2044.1982.tb01102.x.
6
Recovery from intravenous anaesthesia. Comparison of disoprofol with thiopentone and methohexitone.静脉麻醉后的恢复。丙泊酚与硫喷妥钠和甲己炔巴比妥的比较。
Anaesthesia. 1982 Dec;37(12):1171-5. doi: 10.1111/j.1365-2044.1982.tb01782.x.
7
Disoprofol and fentanyl for total intravenous anaesthesia.丙泊酚与芬太尼用于全静脉麻醉。
Anaesthesia. 1982 May;37(5):541-7. doi: 10.1111/j.1365-2044.1982.tb01224.x.
8
Extended blood collection period required to define distribution and elimination kinetics of propofol.确定丙泊酚的分布和消除动力学需要延长采血时间。
Br J Clin Pharmacol. 1988 Aug;26(2):187-90. doi: 10.1111/j.1365-2125.1988.tb03386.x.
9
Induction and maintenance of propofol anaesthesia. A manual infusion scheme.丙泊酚麻醉的诱导与维持:一种手动输注方案
Anaesthesia. 1988 Mar;43 Suppl:14-7. doi: 10.1111/j.1365-2044.1988.tb09061.x.
10
An investigation of the pharmacokinetic profile of propofol ('Diprivan') after administration for induction and maintenance of anaesthesia by repeat bolus doses in patients having spinal anaesthetic block.在接受脊髓麻醉阻滞的患者中,通过重复推注剂量给药用于诱导和维持麻醉后丙泊酚(“得普利麻”)药代动力学特征的研究。
Postgrad Med J. 1985;61 Suppl 3:60-1.

引用本文的文献

1
The role of population pharmacokinetics in drug development in light of the Food and Drug Administration's 'Guidance for Industry: population pharmacokinetics'.根据美国食品药品监督管理局的《工业指南:群体药代动力学》,群体药代动力学在药物研发中的作用
Clin Pharmacokinet. 2000 Dec;39(6):385-95. doi: 10.2165/00003088-200039060-00001.
2
Predicting effective drug concentrations for individual patients. Determinants of pharmacodynamic variability.预测个体患者的有效药物浓度。药效学变异性的决定因素。
Clin Pharmacokinet. 1998 Apr;34(4):323-33. doi: 10.2165/00003088-199834040-00005.
3
Propofol for sedation in a mentally retarded dental patient.
丙泊酚用于一名智障牙科患者的镇静
Anesth Prog. 1994;41(3):81-2.
4
Anaesthesia for coronary artery surgery--a plea for a goal-directed approach.冠状动脉手术的麻醉——呼吁采用目标导向方法。
Can J Anaesth. 1993 Dec;40(12):1178-94. doi: 10.1007/BF03009608.
5
Clinical pharmacokinetics of the newer intravenous anaesthetic agents.新型静脉麻醉药的临床药代动力学
Clin Pharmacokinet. 1986 Jan-Feb;11(1):18-35. doi: 10.2165/00003088-198611010-00002.
6
Propofol. A review of its pharmacodynamic and pharmacokinetic properties and use as an intravenous anaesthetic.丙泊酚。对其药效学和药代动力学特性以及作为静脉麻醉剂的应用的综述。
Drugs. 1988 Apr;35(4):334-72. doi: 10.2165/00003495-198835040-00002.
7
Extended blood collection period required to define distribution and elimination kinetics of propofol.确定丙泊酚的分布和消除动力学需要延长采血时间。
Br J Clin Pharmacol. 1988 Aug;26(2):187-90. doi: 10.1111/j.1365-2125.1988.tb03386.x.
8
Pharmacokinetic implications for the clinical use of propofol.丙泊酚临床应用的药代动力学影响
Clin Pharmacokinet. 1989 Nov;17(5):308-26. doi: 10.2165/00003088-198917050-00002.
9
The use of kinetic-dynamic interactions in the evaluation of drugs.动力学-动态相互作用在药物评估中的应用。
Psychopharmacology (Berl). 1990;100(4):433-50. doi: 10.1007/BF02243994.